{
  "id": "everyday#risk_safety_5229f21e",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "is needed for better pre-hospital sodium valproate, the teratogenic effects may vary. management of seizures. 77 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders EPI2. In children with established status epilepticus, i.e. seizures persisting after the first-line agent (benzodiazepine-resistant status epilepticus), which antiseizure medicines are associated with better clinical outcomes (stopping seizures and with less adverse effects)? Recommendation (update): In children with established status epilepticus, i.e. seizures persisting after two doses of benzodiazepines, intravenous fosphenytoin, intravenous phenytoin, intravenous levetiracetam, intravenous phenobarbital or intravenous valproic acid (sodium valproate) should be considered with appropriate monitoring. The choice of these medicines depends on local resources, including availability and facilities for monitoring. Strength of recommendation: Conditional Certainty of evidence: Moderate Justification Remarks y A new systematic review and meta-analysis was y Status epilepticus is a medical emergency which can conducted to study comparisons between the lead to profound systemic and neurological damage ASMs for status epilepticus in children: Sharma et and is associated with significant short-term and al., 2023 (12 RCTs).13 There is moderate- to high- long-term mortality. Timely control of status quality evidence that there is no clinically important epilepticus is of paramount importance to improve difference in efficacy between intravenous the outcomes. phenytoin, fosphenytoin, levetiracetam or sodium y A staged treatment protocol for management of valproate for the treatment of benzodiazepine- status epilepticus is recommended. resistant status epilepticus in children. There is – Approximately 30–40% of all individuals fail to low-quality evidence that phenobarbital may be respond to initial treatment with benzodiazepines more effective than phenytoin or sodium valproate (benzodiazepine-resistant or established status in the treatment of benzodiazepine-resistant status epilepticus) and need further treatment with epilepticus in children. other intravenous ASM, i.e. established status y Another factor of concern is the speed of epilepticus. The treatment of established status administration. Fosphenytoin, levetiracetam and epilepticus is the focus of this recommendation sodium valproate can be administered within 10 with the above medicines initiated when seizures minutes, whereas phenytoin and phenobarbital persist after two doses of benzodiazepines. need to be infused over 20 minutes. Time is of the y Both levetiracetam and sodium valproate are broad essence while treating status epilepticus. spectrum drugs active against all types of seizures, y There is low- to moderate-quality evidence that and hence may be a good agent for maintenance the safety profile of levetiracetam was better than therapy after the acute control of seizures in children fosphenytoin, phenytoin or sodium valproate in with genetic generalized epilepsy or when the terms of less requirement for intubation, and lesser type of seizure/epilepsy syndrome is not clear. If overall adverse effects. available, intravenous levetiracetam should be y There is insufficient evidence to recommend the use considered because of its superior safety profile. of lacosamide or diazepam infusion at this time. 13 Sharma S, Jain P, Aneja S. Antiseizure medicine treatment for established status epilepticus in adults. 2023 (in preparation). 78",
  "gloss_vi": "Is needed for better pre-hospital sodium valproate, the teratogenic effects may vary. management of seizures.",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety"
    ],
    "life_topics": [
      "study"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn is needed for better pre-hospital sodium valproate, the teratogenic effects may vary. management of seizures. 77 Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders EPI2. In children with established status epilepticus, i.e. seizures persisting after the first-line agent (benzodiazepine-resistant status epilepticus), which antiseizure medicines are associated with better clinical outcomes (stopping seizures and with less adverse effects)? Recommendation (update): In children with established status epilepticus, i.e. seizures persisting after two doses of benzodiazepines, intravenous fosphenytoin, intravenous phenytoin, intravenous levetiracetam, intravenous phenobarbital or intravenous valproic acid (sodium valproate) should be considered with appropriate monitoring. The choice of these medicines depends on local resources, including availability and facilities for monitoring. Strength of recommendation: Conditional Certainty of evidence: Moderate Justification Remarks y A new systematic review and meta-analysis was y Status epilepticus is a medical emergency which can conducted to study comparisons between the lead to profound systemic and neurological damage ASMs for status epilepticus in children: Sharma et and is associated with significant short-term and al., 2023 (12 RCTs).13 There is moderate- to high- long-term mortality. Timely control of status quality evidence that there is no clinically important epilepticus is of paramount importance to improve difference in efficacy between intravenous the outcomes. phenytoin, fosphenytoin, levetiracetam or sodium y A staged treatment protocol for management of valproate for the treatment of benzodiazepine- status epilepticus is recommended. resistant status epilepticus in children. There is – Approximately 30–40% of all individuals fail to low-quality evidence that phenobarbital may be respond to initial treatment with benzodiazepines more effective than phenytoin or sodium valproate (benzodiazepine-resistant or established status in the treatment of benzodiazepine-resistant status epilepticus) and need further treatment with epilepticus in children. other intravenous ASM, i.e. established status y Another factor of concern is the speed of epilepticus. The treatment of established status administration. Fosphenytoin, levetiracetam and epilepticus is the focus of this recommendation sodium valproate can be administered within 10 with the above medicines initiated when seizures minutes, whereas phenytoin and phenobarbital persist after two doses of benzodiazepines. need to be infused over 20 minutes. Time is of the y Both levetiracetam and sodium valproate are broad essence while treating status epilepticus. spectrum drugs active against all types of seizures, y There is low- to moderate-quality evidence that and hence may be a good agent for maintenance the safety profile of levetiracetam was better than therapy after the acute control of seizures in children fosphenytoin, phenytoin or sodium valproate in with genetic generalized epilepsy or when the terms of less requirement for intubation, and lesser type of seizure/epilepsy syndrome is not clear. If overall adverse effects. available, intravenous levetiracetam should be y There is insufficient evidence to recommend the use considered because of its superior safety profile. of lacosamide or diazepam infusion at this time. 13 Sharma S, Jain P, Aneja S. Antiseizure medicine treatment for established status epilepticus in adults. 2023 (in preparation). 78 Is needed for better pre-hospital sodium valproate, the teratogenic effects may vary. management of seizures."
}